6 March 2019
Rinicare announces PRIME product launch
Rinicare's PRIME is ready for use: Remote monitoring? ✔ … Thermometer? ✔ … BP Cuff? ✔ … Pulse Oximeter? ✔ … Full 12 Lead ECG? ✔ … Connects to user's device? ✔ … Integrated with EMIS and SystmOne? ✔ … Produces dynamic National Early Warning Score? ✔ … PRIME is the only solution...
19 February 2019
UK AI companies Biorelate and Intellegens win share of £20m in Innovate UK grant competition to explore creation of advanced data curation tool
2019-02-18. Manchester, UK and Cambridge, UK. Two artificial intelligence (AI) companies, Biorelate Limited and Intellegens Limited, today announced their success in the third round of the Innovate UK open grant funding competition. Together, the two companies have secured over...
12 February 2019
Nexus Labs welcomes new Senior Clinical Editor
Nexus Labs has announced the appointment of a new Senior Clinical Editor: Dr Wen Ling Choong. Wen, a graduate of the University of Dundee, is currently a Speciality Registrar Year 5 (ST5) in General Surgery at Ninewells Hospital. She is also undertaking an MBA at Imperial...
6 February 2019
Yospace sale to RTL to generate an expected 6.7x return for Catapult Ventures
Luxembourg/London, 8 January 2019 – RTL Group today announced that it has signed an agreement to acquire control of the UK-based video technology company Yospace. The transaction is expected to close 1 February 2019. Yospace has developed one of the most advanced...
30 January 2019
Apex Molecular Plans Expansion Following Rebrand
One of the country’s fastest growing specialist contract research organisations has today unveiled a new name and brand. Apex Molecular, formerly YProtech, is a provider of synthetic chemistry services and operates from a base at Alderley Park in Cheshire. The rise of...
29 January 2019
AMR Centre hails government action plan as ‘critical step’ in tackling antibiotic crisis
24th January 2019. The AMR Centre has today welcomed the UK Government’s announcement of a new plan to cut inappropriate use of antibiotics and reduce drug resistant infections. The national action plan, announced by Health Secretary Matt Hancock at the World Economic...
15 January 2019
Gendius announces launch of Intellin®
Diabetes app to prevent complications from diabetes … Alderley Park, UK – 10th January 2019 … The NHS spends 10% of its budget or £14 billion on treating diabetes and its complications. Today Gendius announced the availability of Intellin® on the Google Play and...
4 January 2019
Peter Hamer joins SurgaColl as Chief Executive Officer
Alderley Park, UK – 10th December 2018. SurgaColl, a regenerative medicine company, today announced the appointment of Peter Hamer as Chief Executive Officer. Mr. Hamer succeeds Bill Allan as CEO following Bill’s decision to retire from full time executive roles.